A Simple-to-Use Nomogram for Predicting the Survival of Early Hepatocellular Carcinoma Patients

被引:38
作者
Chen, Si-Hai [1 ]
Wan, Qin-Si [1 ]
Zhou, Di [2 ]
Wang, Ting [1 ]
Hu, Jia [1 ]
He, Yu-Ting [1 ]
Yuan, Hai-Liang [1 ]
Wang, Yu-Goi [1 ]
Zhang, Kun-He [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Jiangxi Inst Gastroenterol & Hepatobgy, Nanchang, Jiangxi, Peoples R China
[2] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth Sci, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
基金
中国国家自然科学基金;
关键词
early hepatocellular carcinoma; nomogram; survival analysis; prediction; clinic utility; CANCER-SPECIFIC SURVIVAL; STAGING-SYSTEM; INDIVIDUAL PROGNOSIS; ALPHA-FETOPROTEIN; SURGICAL THERAPY; CELL CARCINOMA; UNITED-STATES; BIOMARKER; RESECTION; ABLATION;
D O I
10.3389/fonc.2019.00584
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study aimed to develop and validate a simple-to-use nomogram for early hepatocellular carcinoma (HCC) patients undergoing a preoperative consultation and doctors conducting a postoperative evaluation. Methods: A total of 2,225 HCC patients confirmed with stage I or II were selected from the Surveillance, Epidemiology, and End Results database between January 2010 and December 2015. The patients were randomly divided into two groups: a training group (n = 1,557) and a validation group (n = 668). Univariate and multivariate hazards regression analyses were used to identify independent prognostic factors. The Akaike information criterion (AIC) was used to select variables for the nomogram. The performance of the nomogram was validated concerning its ability of discrimination and calibration and its clinical utility. Results: Age, alpha-fetoprotein (AFP), race, the degree of differentiation, and therapy method were significantly associated with the prognosis of early HCC patients. Based on the AIC results, five variables (age, race, AFP, degree of differentiation, and therapy method) were incorporated into the nomogram. The concordance indexes of the simple nomogram in the training and validation groups were 0.707 (95% CI: 0.683-0.731) and 0.733 (95% CI: 0.699-0.767), respectively. The areas under the receiver operating characteristic (ROC) curve of the nomogram in the training and validation groups were 0.744 and 0.764, respectively, for predicting 3-year survival, and 0.786 and 0.794, respectively, for predicting 5-year survival. Calibration plots showed good consistency between the predictions of the nomogram and the actual observations in both the training and validation groups. Decision curve analysis (DCA) showed that the simple nomogram was clinically useful, and the overall survival significantly differed between low-and high-risk groups divided by the median score of the nomogram in the training group (P < 0.001). Conclusion: A simple-to-use nomogram based on a large population-based study is developed and validated, which is a conventional tool for doctors to facilitate the individual consultation of preoperative patients and the postoperative personalized evaluation.
引用
收藏
页数:11
相关论文
共 47 条
  • [1] Thirty-Day Readmission Among Patients With Non-Variceal Upper Gastrointestinal Hemorrhage and Effects on Outcomes
    Abougergi, Marwan S.
    Peluso, Heather
    Saltzman, John R.
    [J]. GASTROENTEROLOGY, 2018, 155 (01) : 38 - +
  • [2] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
    Amin, Mahul B.
    Greene, Frederick L.
    Edge, Stephen B.
    Compton, Carolyn C.
    Gershenwald, Jeffrey E.
    Brookland, Robert K.
    Meyer, Laura
    Gress, Donna M.
    Byrd, David R.
    Winchester, David P.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 93 - 99
  • [3] Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinoma
    Asrih, Mohamed
    Lenglet, Sebastien
    Mach, Francois
    Montecucco, Fabrizio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (03) : 328 - 330
  • [4] X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    Camp, RL
    Dolled-Filhart, M
    Rimm, DL
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7252 - 7259
  • [5] Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
    Chun, Yoon Hee
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Kim, Beom Kyung
    Choi, Gi Hong
    Kim, Kyung Sik
    Choi, Jin Sub
    Ahn, Sang Hoon
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (17) : 2568 - 2575
  • [6] Racial differences in survival of hepatocellular carcinoma in the United States: A population-based study
    Davila, JA
    El-Serag, HB
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (01) : 104 - 110
  • [7] Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder
    Dong, Fan
    Shen, Yifan
    Gao, Fengbin
    Shi, Xiao
    Xu, Tianyuan
    Wang, Xianjin
    Zhang, Xiaohua
    Zhong, Shan
    Zhang, Minguang
    Chen, Shanwen
    Shen, Zhoujun
    [J]. JOURNAL OF CANCER, 2018, 9 (07): : 1152 - 1164
  • [8] Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States
    El-Serag, HB
    Mason, AC
    Key, C
    [J]. HEPATOLOGY, 2001, 33 (01) : 62 - 65
  • [9] European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.ejca.2011.12.021, 10.1016/j.jhep.2011.12.001]
  • [10] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019